Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

KAMIYA BIOMEDICAL COMPANY, LLC

United States·US-MF-000002769

Last updated May 24, 2026

What KAMIYA BIOMEDICAL COMPANY, LLC makes

KAMIYA BIOMEDICAL COMPANY, LLC manufactures in vitro diagnostic (IVD) products including reagents, calibrators, and controls for various biomarkers such as C-reactive protein (CRP), plasma proteins, microalbumin, glycated hemoglobin (HbA1c), and Beta-2-microglobulin. Their product portfolio includes specific devices like the K-ASSAY® Hemoglobin A1c Control, K-ASSAY® Prealbumin Calibrator, and K-ASSAY® Cystatin C Reagent (L), among others.

The company's devices are regulated and listed in multiple registries including EUDAMED, FDA 510(k), and FDA UDI, with device classes ranging from Class I to Class II. KAMIYA BIOMEDICAL COMPANY, LLC is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What does KAMIYA BIOMEDICAL COMPANY, LLC manufacture?

KAMIYA BIOMEDICAL COMPANY, LLC manufactures in vitro diagnostic (IVD) products including reagents, calibrators, and controls for various biomarkers such as C-reactive protein (CRP), plasma proteins, microalbumin, glycated hemoglobin (HbA1c), and Beta-2-microglobulin.

Where is KAMIYA BIOMEDICAL COMPANY, LLC based?

KAMIYA BIOMEDICAL COMPANY, LLC is based in the United States, as indicated by the country information provided in the device data.

Which regulatory registries list KAMIYA BIOMEDICAL COMPANY, LLC's devices?

The company's devices are listed in multiple regulatory registries including EUDAMED, FDA 510(k), and FDA UDI, as specified in the device data.

How are KAMIYA BIOMEDICAL COMPANY, LLC's devices classified?

The company's devices are classified under different regulatory classes ranging from Class I to Class II, with Class B also mentioned, as indicated in the device data.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
12779 Gateway Drive S., Tukwila, WA, United States
LinkedIn
—
Facebook
—
Phone
+1 206-575-8068
PRRC Contact
Colin Getty
EUDAMED SRN
US-MF-000002769
FDA FEI Number
—
DUNS Number
197934250

Catalogue (162)

Page 4 of 4
DeviceModel / ReferenceRegistriesClassStatus
K-Assay Total Ige, K-Assay Ige Calibrator Set, Models Kai-092/Kai-093c K042241
FDA 510(k)
Class IIActive
K-Assay C-Reactive Protein (3), K-Assay Crp Multi-Calibrator D, K-Assay Crp Multi-Calibrator E, K-Assay Crp Multi-Calibr K023828
FDA 510(k)
Class IIActive
K-Assay D-Dimer, K-Assay D-Dimer Calibrator, Models Kai-090; Kaj-091c K030687
FDA 510(k)
Class IIActive
K-Assay Multi-Analyte Calibrator K993853
FDA 510(k)
Class IIActive
K-Assay C4 K993481
FDA 510(k)
Class IIActive
Aso/Crp/Rf Controls For Immunoturbidimetric Assays K983241
FDA 510(k)
Class IActive
K-Assay (r) Ferritin Reagent, K-Assay (r) Ferritin Calibrator K121232
FDA 510(k)
Class IIActive
Determiner Pl/Determination Of Phospholipids K905829
FDA 510(k)
Class IActive
K-Assay Hs-Crp Controls K011079
FDA 510(k)
Class IIActive
Factor XIII KAI-205
EUDAMEDFDA UDI
Class BActive
Factor XIII Calibrator KAI-206C
EUDAMEDFDA UDI
Class BActive
Coagulation Control K204C-10M
EUDAMEDFDA UDI
Class BActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (6)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Kamiya Biomedical Company, LLC has six recall records initiated between March 29, 2004, and September 28, 2022, with statuses including open, classified, and terminated. The reasons cited involve inconsistencies in assay results, potential long-term stability issues with specific reagents, incorrect vial contents, inaccurate calibrator values in package inserts, and mismatches in reagent performance standardization.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Sep 28, 2022Z-0271-2023—open, classified

IgA Reagent may start showing cloudiness over time, which can affect assay performance.

Jul 19, 2017Z-3138-2017—terminated

The AlAT calibrator values in the package insert for the Multi-Analyte Calibrator, lot D755, lots N653 and lot N654 were not correct.

May 1, 2009Z-0973-2010—terminated

The long-term stability of level 2 (1.0 mg/dL) may not be within the specifications due to a decrease in CRP concentration.

Sep 17, 2008Z-0923-2011—terminated

Standardization of the reagent performance data did not match the standardization used to assign the calibrator values.

Apr 11, 2006Z-0850-06—terminated

Kits may contain 2 vials of the same reagent instead of 1 vial of buffer reagent and 1 vial of antibody reagent

Mar 29, 2004Z-0940-04—terminated

Assay result not consistent with the assigned control value